Gian Fulgoni Net Worth

The estimated Net Worth of Gian Fulgoni is at least $52.1 Million dollars as of 9 November 2023. Gian Fulgoni owns over 41,000 units of Petmed Express stock worth over $371,239 and over the last 20 years he sold PETS stock worth over $51,525,229. In addition, he makes $159,850 as Independent Director at Petmed Express.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Gian Fulgoni PETS stock SEC Form 4 insiders trading

Gian has made over 55 trades of the Petmed Express stock since 2007, according to the Form 4 filled with the SEC. Most recently he bought 41,000 units of PETS stock worth $300,940 on 9 November 2023.

The largest trade he's ever made was exercising 217,891 units of Petmed Express stock on 21 August 2012 worth over $54,473. On average, Gian trades about 16,079 units every 47 days since 2004. As of 9 November 2023 he still owns at least 109,510 units of Petmed Express stock.

You can see the complete history of Gian Fulgoni stock trades at the bottom of the page.

Gian Fulgoni biography

Dr. Gian M. Fulgoni serves as Independent Director of the Company. Dr. Fulgoni had previously been a member of our Board of Directors from August 1999 through November 2000, but left to devote his time to comScore, Inc., (at that time, ComScore Networks, Inc.), (NASDAQ:SCOR), a digital data and analytics company that he had co-founded, and now a recognized global leader in measuring the cross-platform world. He served on the comScore board from 1999 until April 2018. He served as Executive Chairman from 1999 to March 2014, Chairman Emeritus from March 2014 to August 2016, and Chief Executive Officer from August 2016 to November 2017. From 1981 until 1998, Dr. Fulgoni served as President and Chief Executive Officer of Information Resources, Inc. (IRI), (then: NASDAQ: IRIC), a leading global supplier of retail scanner data and software services to the Consumer Packaged Goods (CPG) industry, where he grew the company’s revenues at an annual rate of 40% to more than $500 million annually and its market value to $1.5 billion. In 1996, IRI was recognized by Advertising Age magazine as the largest U.S. market research firm. Additionally, by the time Dr. Fulgoni joined the Company’s Board, he had already been involved in the growth of other successful public companies. From 1991 until 1999, he served as a member of the board of Platinum Technology, Inc., during which time the company grew from $80 million to more than $1 billion in annual revenues and established itself as a global leader in the software services industry. In 1999, Platinum Technology was acquired by Computer Associates in an all-cash transaction valued at $4.0 billion -- at the time the largest-ever acquisition in the software industry.

What is the salary of Gian Fulgoni?

As the Independent Director of Petmed Express, the total compensation of Gian Fulgoni at Petmed Express is $159,850. There are 4 executives at Petmed Express getting paid more, with Menderes Akdag having the highest compensation of $1,303,460.

How old is Gian Fulgoni?

Gian Fulgoni is 72, he's been the Independent Director of Petmed Express since 2002. There are 3 older and 5 younger executives at Petmed Express. The oldest executive at Petmed Express, Inc. is Ronald Korn, 80, who is the Independent Director.

Insiders trading at Petmed Express

Over the last 24 years, insiders at Petmed Express have traded over $24,134,502 worth of Petmed Express stock and bought 61,738 units worth $451,498 . The most active insiders traders include Gian Fulgoni, Menderes Akdag, and Robert C Schweitzer. On average, Petmed Express executives and independent directors trade stock every 36 days with the average trade being worth of $26,079. The most recent stock trade was executed by Jacqueline Paula Smith on 15 August 2024, trading 601 units of PETS stock currently worth $1,917.

What does Petmed Express do?

petmeds® is america's largest pet pharmacy, a publicly traded company (nasdaq: pets). we deliver prescription and non-prescription pet meds along with health and nutritional supplements for dogs, cats and horses at substantial savings directly to you. we serve millions of satisfied customers nationwide from one location.

Complete history of Gian Fulgoni stock trades at Petmed Express and Comscore

Petmed Express executives and stock owners

Petmed Express executives and other stock owners filed with the SEC include:

• Menderes Akdag,
  President, Chief Executive Officer, Director
• Bruce Rosenbloom,
  Chief Financial Officer, Treasurer
• Bruce S. Rosenbloom,
  CFO & Treasurer
• Robert Schweitzer,
  Independent Chairman of the Board
• Ronald Korn,
  Independent Director
• Gian Fulgoni,
  Independent Director
• Frank Formica,
  Independent Director
• Leslie Campbell,
  Independent Director
• Matthew N. Hulett,
  CEO, Pres & Director
• Wendy Zalai,
  Corp. Controller & Corp. Sec.
• Diana G Purcel,
  Director
• Peter Cobb,
  Director
• Jodi Watson,
  Director
• Guren Kivilcim,
  Director
• Marc Mdmarpul Investments L...,
  
• Holdings Llc Tricon,
  10% owner
• Marc Md Puleo,
  President/Chairman of Board
• Ltd Creslin,
  10% owner
• Marc Mdmarpul Trust / South...,
  
• Leah Solivan,
  Director
• Jacqueline Paula Smith,
  
• Daniel Job Pingree,
  
• Mark Bradley Jr Moseley,
  
• Christine Chambers,
  CFO
• Mathew N Hulett,
  
• Sandra Yvette Campos,
  CEO & President
• Justin L. Mennen,
  Director